BAC vs DYN Stock Comparison

BAC currently leads DYN in this stock comparison, with AIQ scores of 58 vs 48. The clearest difference is risk resilience, while DYN has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 10 points
BAC
Financial Services
vs
DYN
Healthcare
BAC
Bank of America Corporation
Leads
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services
DYN
Dyne Therapeutics, Inc.
Price
$17.16
Day move
+0.88%
AIQ Score
48/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BAC and DYN?

BAC leads the current stock comparison as Bank of America Corporation, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs Dyne Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

BAC leads

BAC leads by 10 AIQ points, primarily on Risk Resilience and Quality, but the lead has narrowed from 19 points over 30 sessions. Wall Street currently favors DYN on target upside.

Fragile: 2 of 5 evidence groups support BAC, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 2 of 5Comparison trend: Weakening
BAC

Bank of America Corporation

Leads
AIQ Score
58/100
AIQ Edge Score
6/10
DYN

Dyne Therapeutics, Inc.

AIQ Score
48/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors BAC over DYN, 58 versus 48 as of Nov 15, 2026. BAC's advantage is driven primarily by stronger risk resilience and quality, while DYN holds the stronger momentum profile. BAC also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors DYN. 2 of 5 covered evidence groups favor BAC today, and the comparison is rated Fragile on stability: only 2 of 5 covered evidence groups agree. BAC lead: Weakening — the AIQ differential moved from 19 to 10 points over 30 sessions.

Compare Bank of America Corporation and Dyne Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+24.0%
DYN
+15.1%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $12,399 · DYN $11,509

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and DYN against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
DYN advantage
  • Risk Resilience83 vs 42
    BAC +41
  • Quality64 vs 47
    BAC +17
  • Momentum37 vs 52
    DYN +15

2 of 5 evidence groups favor BAC. BAC’s edge is concentrated in risk resilience and quality; DYN keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
DYN+1 AIQ

Largest factor move: Momentum +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)

BAC's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and DYN both carry a full feed there.

The central trade-off

BAC (Bank of America Corporation): the stronger current systematic profile, led by risk resilience and quality.

DYN (Dyne Therapeutics, Inc.): the counter-case, on momentum, technicals, analyst expectations — but at materially higher volatility, 62.6% against 24.8%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BAC

BAC on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

DYN

DYN on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

DYN

DYN on the Momentum factor, by 15 points.

Lower downside

BAC

BAC on Risk Resilience, by 41 points.

Analyst upside

DYN

DYN on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors BAC, analyst targets favor DYN. That disagreement is the most useful thing on this page.

MeasureBACDYNNote
Implied upside to target+24.1%+114.9%DYN has more room
Target dispersion+25.3%+65.1%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2517Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 5 covered evidence groups favor BAC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBAC58 vs 48
FundamentalsEvenEPS growth -23.8% vs 1.9%; TTM ROE 2.3% vs -20.8%
ValuationNot coveredNot covered
TechnicalsDYNPrice vs 50-day -5.6% vs 1.2%; vs 200-day -7% vs -11.2%
Risk ResilienceBACRisk Resilience 83 vs 42
Analyst expectationsDYNTarget upside 24.1% vs 114.9%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and DYN and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 10 points.
  • Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BAC.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

BAC lead: Weakening — the AIQ differential moved from 19 to 10 points over 30 sessions.

May 27BAC leads above the line · DYN leads belowNov 13
Today
BAC +10
58 vs 48
7 sessions ago
BAC +11
58 vs 47
30 sessions ago
BAC +19
62 vs 43
90 sessions ago
BAC +7
71 vs 64

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
DYNConflicted

1 bullish / 3 bearish / 2 neutral, conflicted

Only DYN

  • ADX Trend Weakening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.51%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 1 more signal that do not separate them: Death Cross Active.

BAC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

DYNConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.88%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1DYN closes the Risk Resilience gap — currently 41 points behind, the largest single contributor to BAC's edge.
  2. 2DYN's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 9 points over 30 sessions, and a further 10-point move would eliminate BAC's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricBACDYN
Revenue growth (YoY)-3.3%0%
EPS growth (YoY)-23.8%1.9%
Gross margin60.4%0%
Operating margin22.4%0%
Return on equity (TTM)2.3%-20.8%
Debt to equity1.280.26

Performance

BAC leads 5 of 6 windows
MetricBACDYN
1 week (5 sessions)3.2%-5%
1 month (20 sessions)-0.4%20.4%
3 months (63 sessions)-20.1%-34.4%
6 months (126 sessions)2.5%-0.8%
Year to date-7.2%-12.3%
1 year (252 sessions)-5.7%-7.8%

Technicals

DYN has the stronger structure
MetricBACDYN
RSI (14)45.949.3
ADX (14)27.220.9
Price vs 50-day-5.6%1.2%
Price vs 200-day-7%-11.2%
Volatility (1M, annualized)24.8%62.6%

Risk

BAC is the more resilient
MetricBACDYN
Beta0.791.71
Sharpe ratio-0.220.11
Sortino ratio-0.290.16
Max drawdown-23.7%-46.8%
Current drawdown-21.3%-35.9%
Annualized volatility22.4%63.9%
Value at risk (95%)-2.6%-5.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or DYN?

On the Algovestiq AIQ Score, BAC is the stronger of the two as of Nov 15, 2026, scoring 58 against DYN's 48. The edge comes from risk resilience and quality. DYN is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or DYN the better buy right now?

BAC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 2 of 5 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor BAC over DYN?

The composite weights Quality, Value, Momentum and Risk Resilience. BAC leads Risk Resilience by 41 points; BAC leads Quality by 17 points; DYN leads Momentum by 15 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or DYN?

Analyst price targets imply +24.1% upside for BAC and +114.9% for DYN, so the Street currently favors DYN. That points the opposite way to the AIQ Score, which favors BAC. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or DYN?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or DYN?

DYN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or DYN?

DYN on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or DYN?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 41 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than DYN?

BAC leads on the comparable margin measures — gross margin 60.4% vs 0%; operating margin 22.4% vs 0%; ttm roe 2.3% vs -20.8%.

Is BAC's lead over DYN getting stronger or weaker?

BAC lead: Weakening — the AIQ differential moved from 19 to 10 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the BAC vs DYN verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DYN closes the Risk Resilience gap — currently 41 points behind, the largest single contributor to BAC's edge; DYN's Death Cross Active resolves — a bearish trend rule currently active against it; BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 9 points over 30 sessions, and a further 10-point move would eliminate BAC's advantage entirely.

What do the current signals say about BAC and DYN?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. DYN: 1 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On DYN it is Death Cross Active (bearish, long horizon).

Compare BAC and DYN with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.